Randomized double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4

AIMS: To evaluate the efficacy and safety of basal insulin peglispro (BIL) with those of insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (T2D). METHODS: In this phase III, multicentre, double‐blind, 26‐week study, we randomized patients with T2D [...

Descripción completa

Detalles Bibliográficos
Autores principales: Blevins, T., Pieber, T. R., Colón Vega, G., Zhang, S., Bastyr, E. J., Chang, A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Themed Section‐bil
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096023/
https://www.ncbi.nlm.nih.gov/pubmed/27234693
http://dx.doi.org/10.1111/dom.12696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096023/
https://www.ncbi.nlm.nih.gov/pubmed/27234693
http://dx.doi.org/10.1111/dom.12696

Ejemplares similares